Article Per Year (5 Year)
p-Index From 2020 - 2025
0.408
P-Index
This Author published in this journals
All Journal Jurnal Farmasi dan Sains Indonesia (JFSI)
Maryeta, Eleonora
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Chemistry Health Professions Medicine & Pharmacology Neuroscience

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Hubungan Antara Kualitas Pelayanan Kefarmasian Pasien Rawat Jalan Dengan Tingkat Kepuasan di Puskesmas X Indrasari, Ferika; Riyantara, Rahma Widya; Maryeta, Eleonora; Suwarni, Sri
Jurnal Farmasi & Sains Indonesia Vol 7 No 1 (2024)
Publisher : LPPM Sekolah Tinggi Ilmu Farmasi Nusaputera

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52216/jfsi.vol7no1p210-217

Abstract

Pharmaceutical service is a responsible service directly to patients related to pharmaceutical preparations with the aim of achieving is to improve patient life quality. Service quality always be complained by patient when get treatment in the Public Health. Worse service, unfriendly, slow service is a factor that affects the quality of service. The level of satisfaction is a comparison function between performance obtained and expectations. When performance is below expectations, the customer will disappointed and vice versa. This research to know the correlation the quality of pharmacy services with outpatient satisfication in the Purwodadi II Public Health. This research used an analytical observational method with a cross sectional design with a sample technique using purposive sampling technique. This data is main data by filling out questionnaires of patients that seeking treatment in the Purwodadi II Health. The process of data analysis in this study are 1. Editing 2. Coding 3. Scoring 4. Tabulating. From the results of this study, it was found that there was a significant relationship between service quality dimensions of reliability, responsiveness, assurance, empathy, and tangibels outpatient pharmacy with the level of satisfaction at Puskesmas Purwodadi II with a p-value of reliability dimension 0.001, responsiveness 0.002, assurance 0.001, empathy 0.000, and tangibels 0.000(p-value<0,05).
Efektivitas Biaya Pengobatan Diare Akut Pada Pasien Anak Rawat Inap di Rumah Sakit X Indrasari, Ferika; Riyadi, Teguh Achmad; Maryeta, Eleonora
Jurnal Farmasi & Sains Indonesia Vol 7 No 1 (2024)
Publisher : LPPM Sekolah Tinggi Ilmu Farmasi Nusaputera

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52216/jfsi.vol7no1p197-202

Abstract

Indonesia in 2021-2022 still obtained a prevalence of 1.3 billion attacks and 3.2 million deaths per year in toddlers due to diarrhoea. Diarrhoea is a disease that kills children under five years of age due to infections that can spread widely in the patient's body. The cost of acute diarrhoea in the hospital is all costs that have been incurred by patients related to medical services. These costs include treatment, medication and laboratory costs. This study aims to determine the Cost Effectiveness of Acute Diarrhoea Treatment in Inpatient Pediatric Patients at Hospital X quantitative data, namely data on pediatric patients with acute diarrhoea from inpatient examinations at Hospital X with Costeffectivinees Analysis (CEA) Research Design which is one of the pharmacoeconomic approaches to determine the comparison of the effectiveness of therapeutic outcomes and the costs of the treatment used. Data collection based on observation sheets (length of treatment, types of drugs used, medical treatment costs, administrative costs, and treatment costs for diagnosis of acute diarrhoea) total cost of acute diarrhoea in inpatient care at X Hospital during July - December 2022. The results of the study on the cost-effectiveness of treatment of acute diarrhoea in paediatric inpatients at Hospital X showed that the use of Orinkz was more effective than the combination of orezinc- nifudiar. Judging from the ACER value of Oriznik of Rp 17,029, - while the combination of orezinc- nifudiar Rp 17,684.
Co-Authors Ferika Indrasari Riyadi, Teguh Achmad Riyantara, Rahma Widya Sri Suwarni